About
Atrial Fibrillation

Atrial Fibrillation (AFib) is common, with a 1 in 4 lifetime risk after age 40. AFib symptoms include fatigue, dizziness, activity intolerance, shortness of breath, and inability to perform activities of daily living. The stagnation of blood increases the risk of thromboembolism and stroke.  

A recent estimate found the number of individuals with AFib was over 33 million and is on the rise. Future projections predict at least five million new cases annually worldwide, with the prevalence in the US cases expected to reach up to 6.7 million by 2050. 

AFib management is not a one-size-fits-all approach, and healthcare providers need to be informed to follow guideline-recommended treatments for patients with AFib.  

Resources

Patient Education Handouts

The Beat Goes On – Living with AFib Booklet

November 12, 2024

Patient Education Handouts

Atrial Fibrilliation Screening Toolkit

November 19, 2024

Patient Education Handouts

Atrial Fibrilliation Screening Event Slides

December 19, 2024

Courses

0 CE contact hours

0 Pharmacology contact hours

0.6 CE contact hours

0.6 Pharmacology contact hours

Free

0.4 CE contact hours

0 Pharmacology contact hours

Free

Podcast Episodes

Atrial Fibrillation, Lifestyle and Behavior Change

Strategies to Activate Your Patients’ Engagement in Atrial Fibrillation Care

Join Dr. Kathy Wood, PhD, RN, FAHA, FAAN, as she explores utilizing…

Atrial Fibrillation, Diagnostics and Devices, Stroke

Rare Arrhythmias: Do You Know What to Look For?

Only 20% of patients with atrial fibrillation are symptomatic for all their…

Atrial Fibrillation, Venous Thromboembolism (VTE)

Exploring the Relationship Between AFib and VTE: Identification and Awareness

Atrial Fibrillation (AFib) and Venous Thromboembolism (VTE) have a risky bidirectional relationship.…